Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

N Engl J Med. 2016 Nov 3;375(18):1801-2. doi: 10.1056/NEJMc1611290.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Blood Glucose
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Glucosides / therapeutic use*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Kidney Diseases / drug therapy
  • Sodium-Glucose Transporter 2

Substances

  • Blood Glucose
  • Glucosides
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2